Erenumab For Treatment of Hemicrania Continua

Summary

This research is being conducting to learn if the study drug erenumab is successful in treating hemicrania continua. The study is also evaluating the safety and tolerability of erenumab in individuals being treated for hemicrania continua.

Timeline

Start

2021-08-04

Primary completion

2022-04-06

Completion

2022-04-06

Drugs

Indications